|
FYCO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23669999999121E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.418100E-04 |
| Normal-vs-Stage2 |
1.114170E-01 |
| Normal-vs-Stage3 |
2.06039999999241E-05 |
| Normal-vs-Stage4 |
3.50289999995201E-06 |
| Stage1-vs-Stage2 |
1.746240E-01 |
| Stage1-vs-Stage3 |
1.512790E-01 |
| Stage1-vs-Stage4 |
2.217800E-02 |
| Stage2-vs-Stage3 |
3.009500E-02 |
| Stage2-vs-Stage4 |
1.070300E-02 |
| Stage3-vs-Stage4 |
4.222400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17439999999902E-05 |
| Normal-vs-AfricanAmerican |
1.432470E-02 |
| Normal-vs-Asian |
2.736900E-03 |
| Caucasian-vs-AfricanAmerican |
9.280000E-01 |
| Caucasian-vs-Asian |
8.824000E-01 |
| AfricanAmerican-vs-Asian |
9.851400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.030330E-04 |
| Normal-vs-Female |
6.03479999999879E-05 |
| Male-vs-Female |
5.826600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.791600E-04 |
| Normal-vs-Age(41-60Yrs) |
4.23449999999992E-05 |
| Normal-vs-Age(61-80Yrs) |
2.805800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.428100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.996400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.846400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.476000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.975000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.796000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.943800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.983800E-03 |
| Classical-VS-Follicular |
6.138200E-01 |
| Classical-VS-Other |
2.761200E-01 |
| Classical-VS-Normal |
5.358300E-04 |
| Tall-VS-Follicular |
2.453900E-02 |
| Tall-VS-Other |
8.651200E-01 |
| Tall-VS-Normal |
2.43769999996868E-06 |
| Follicular-VS-Other |
3.646600E-01 |
| Follicular-VS-Normal |
1.259070E-03 |
| Other-VS-Normal |
2.730400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.591600E-04 |
| Normal-vs-N1 |
1.87901999999518E-05 |
| N0-vs-N1 |
5.585800E-02 |
|
|
